Header Logo

Rajender Aparasu

TitleProfessor
InstitutionUniversity of Houston
DepartmentPharmaceutical Health Outcomes and Policy
Address4800 Calhoun Rd
Houston TX 77004
vCardDownload vCard

    Collapse Research 
    Collapse research activities and funding
    R01HS029501     (APARASU, RAJENDER R)Aug 1, 2023 - May 31, 2027
    NIH
    Deprescribing of Disease Modifying Agents in Older Adults with Multiple Sclerosis
    Role: Principal Investigator
    R13AG071364     (APARASU, RAJENDER R)Aug 1, 2021 - Jul 31, 2026
    NIH
    Geriatric Medication Safety Symposium
    Role: Principal Investigator
    R03HS028502     (APARASU, RAJENDER R)Jul 1, 2021 - Jun 30, 2024
    NIH
    Oral Adherence Trajectories Of Disease Modifying Agents And Associated Relapse Rates Among Patients With Multiple Sclerosis
    Role: Principal Investigator
    R56AG067618     (APARASU, RAJENDER R)Sep 1, 2020 - Aug 31, 2021
    NIH
    Impact of Prescribing Cascade and Associated Drug Interaction in Alzheimer's Disease
    Role: Principal Investigator
    R15AG056997     (APARASU, RAJENDER R)Jul 15, 2017 - Jun 30, 2021
    NIH
    SAFETY PROFILE OF ANTIMUSCARINICS IN ELDERLY DEMENTIA PATIENTS
    Role: Principal Investigator
    R01HS021264     (APARASU, RAJENDER R)Sep 30, 2012 - Jul 31, 2018
    NIH
    Anticholinergics and Cognitive Decline in the Elderly with Depression
    Role: Principal Investigator
    R03HS016920     (APARASU, RAJENDER R.)Apr 1, 2009 - Sep 30, 2011
    NIH
    Impact of Atypical Antipsychotic Use on Health Care Utilization in the Elderly
    Role: Principal Investigator
    R03HS010813     (APARASU, RAJENDER R.)Sep 1, 2000 - Aug 31, 2003
    NIH
    EVALUATION OF INAPPROPRIATE PSYCHOTROPIC USE IN ELDERLY
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Chikermane SG, Li J, Aparasu RR. Risk of Antipsychotic Initiation Among Older Dementia Patients Initiating Cholinesterase Inhibitors. Drug Healthc Patient Saf. 2025; 17:75-85. PMID: 40129750; PMCID: PMC11932038.
      Citations:    
    2. Aparasu RR, Talwar A. Response to comment on "Delirium event and associated treatment modifications among older adults with Alzheimer's disease: An interrupted time-series analysis of Medicare data". Pharmacotherapy. 2025 Jan; 45(1):71. PMID: 39846360.
      Citations:    Fields:    
    3. Olateju OA, Li J, Thornton JD, Aparasu RR. Marginal health care expenditures for melanoma care in the United States. J Manag Care Spec Pharm. 2024 Dec; 30(12):1364-1374. PMID: 39612258; PMCID: PMC11607212.
      Citations:    Fields:    Translation:Humans
    4. Li J, Hutton GJ, Varisco TJ, Lin Y, Essien EJ, Aparasu RR. Comparative effectiveness of high-efficacy and moderate efficacy disease-modifying agents in reducing the annualized relapse rates among multiple sclerosis patients in the United States. Prev Med. 2025 Jan; 190:108180. PMID: 39557306.
      Citations:    Fields:    Translation:Humans
    5. Li J, Hutton GJ, Varisco TJ, Lin Y, Essien EJ, Aparasu RR. Infection Risk Associated with High-Efficacy Disease-Modifying Agents in Multiple Sclerosis: A Retrospective Cohort Study. Clin Pharmacol Ther. 2025 Feb; 117(2):561-569. PMID: 39547934.
      Citations:    Fields:    
    6. Gohil S, Chen H, Lewis WE, Trivedi M, Aparasu RR, Johnson ML. Factors associated with the use of immune checkpoint inhibitors in older adults with metastatic non-small cell lung cancer and pre-existing autoimmune disease: A SEER-Medicare study. J Geriatr Oncol. 2024 11; 15(8):102071. PMID: 39312847.
      Citations:    Fields:    Translation:Humans
    7. Li J, Hutton GJ, Varisco TJ, Lin Y, Essien EJ, Aparasu RR. Factors associated with the initiation of high-efficacy disease-modifying agents over moderate-efficacy disease-modifying agents in multiple sclerosis. Mult Scler Relat Disord. 2024 Nov; 91:105896. PMID: 39342811.
      Citations:    Fields:    Translation:Humans
    8. Chikermane SG, Li J, Aparasu RR. Risk of antimuscarinic initiation with cholinesterase inhibitor use in Alzheimer's disease. Arch Gerontol Geriatr. 2025 Jan; 128:105629. PMID: 39303423.
      Citations:    Fields:    Translation:Humans
    9. Talwar A, Chatterjee S, Abughosh S, Johnson M, Sherer J, Aparasu RR. Delirium event and associated treatment modifications among older adults with Alzheimer's disease: An interrupted time-series analysis of Medicare data. Pharmacotherapy. 2024 Oct; 44(10):782-793. PMID: 39287108.
      Citations:    Fields:    Translation:Humans
    10. Sanyal S, Rowan PJ, Ochoa-Perez M, Calarge C, Aparasu R, Abughosh S, Chen H. Metabolic Monitoring for Children and Adolescents Prescribed Second-Generation Antipsychotics: A Qualitative Study with Child Psychiatrists. J Child Adolesc Psychopharmacol. 2024 10; 34(8):359-365. PMID: 39178123.
      Citations:    Fields:    Translation:Humans
    11. Khalid J, Aparasu RR. Adverse effects associated with antipsychotic use in older adults. Expert Opin Drug Saf. 2024 Sep; 23(9):1157-1171. PMID: 39076106.
      Citations: 1     Fields:    Translation:Humans
    12. Westra J, Raji M, Baillargeon J, Aparasu RR, Kuo YF. Patterns of gabapentinoid use among long-term opioid users. Prev Med. 2024 Aug; 185:108046. PMID: 38897356.
      Citations:    Fields:    Translation:Humans
    13. Earla JR, Li J, Hutton GJ, Bentley JP, Aparasu RR. Association of oral disease-modifying agents and their adherence trajectories with annual relapses in multiple sclerosis. Mult Scler Relat Disord. 2024 May; 85:105539. PMID: 38574721.
      Citations:    Fields:    Translation:Humans
    14. Talwar A, Chatterjee S, Sherer J, Abughosh S, Johnson M, Aparasu RR. Cumulative Anticholinergic Burden and its Predictors among Older Adults with Alzheimer's Disease Initiating Cholinesterase Inhibitors. Drugs Aging. 2024 Apr; 41(4):339-355. PMID: 38467994.
      Citations: 1     Fields:    Translation:Humans
    15. Nair AA, Placencia JL, Farber HJ, Aparasu RR, Johnson M, Chen H. Pain-related hospitalization and emergency room visit following initial analgesic prescription after outpatient surgery. Pharmacoepidemiol Drug Saf. 2024 02; 33(2):e5759. PMID: 38357824.
      Citations:    Fields:    Translation:Humans
    16. Huang Y, Li J, Li M, Aparasu RR. Application of machine learning in predicting survival outcomes involving real-world data: a scoping review. BMC Med Res Methodol. 2023 11 13; 23(1):268. PMID: 37957593; PMCID: PMC10641971.
      Citations: 2     Fields:    
    17. Nair AA, Placencia JL, Farber HJ, Aparasu RR, Johnson M, Chen H. Trends in Repeat Opioid Analgesic Prescription Utilization for Acute Pain in Children: 2013-2018. Acad Pediatr. 2024 07; 24(5):776-782. PMID: 37802247.
      Citations:    Fields:    Translation:Humans
    18. Sanyal S, Calarge C, Rowan PJ, Aparasu RR, Abughosh S, Sisley S, Chen H. Adherence to Recommended Metabolic Monitoring of Children and Adolescents Taking Second-Generation Antipsychotics. Psychiatr Serv. 2024 Apr 01; 75(4):342-348. PMID: 37789728.
      Citations:    Fields:    Translation:Humans
    19. Kwak MJ, Wang Q, Onyebeke C, Holder T, Goyal P, Aparasu R, Dhoble A, Holmes HM. How do we define high and low dose intensity of heart failure medications: a scoping review. BMC Cardiovasc Disord. 2023 09 27; 23(1):478. PMID: 37759279; PMCID: PMC10523693.
      Citations:    Fields:    
    20. Sanyal S, Lyu N, Calarge C, Rowan PJ, Aparasu RR, Abughosh S, Chen H. Association Between Abnormal Metabolic Parameters and Receiving Subsequent Interventions in Children and Adolescents Initiating Second-Generation Antipsychotics. J Child Adolesc Psychopharmacol. 2023 09; 33(7):269-278. PMID: 37676976.
      Citations:    Fields:    Translation:Humans
    21. Talwar A, Lopez-Olivo MA, Huang Y, Ying L, Aparasu RR. Performance of advanced machine learning algorithms overlogistic regression in predicting hospital readmissions: A meta-analysis. Explor Res Clin Soc Pharm. 2023 Sep; 11:100317. PMID: 37662697; PMCID: PMC10474076.
      Citations: 3     
    22. Huang Y, Agarwal SK, Chen H, Chatterjee S, Johnson ML, Aparasu RR. Real-world Comparative Effectiveness of Methotrexate-based Combinations for Rheumatoid Arthritis: A Retrospective Cohort Study. Clin Ther. 2023 09; 45(9):e177-e186. PMID: 37573225.
      Citations:    Fields:    Translation:Humans
    23. Huang Y, Agarwal SK, Chatterjee S, Chen H, Johnson ML, Aparasu RR. Risk of incident cardiovascular events with disease-modifying anti-rheumatic drugs among adults with rheumatoid arthritis: a nested case-control study. Clin Rheumatol. 2024 Jan; 43(1):103-116. PMID: 37540382.
      Citations:    Fields:    Translation:Humans
    24. Huang Y, Aparasu RR, Varisco TJ. Outpatient opioid prescribing by Alzheimer's diagnosis among older adults with pain in United States. BMC Geriatr. 2023 08 01; 23(1):465. PMID: 37528367; PMCID: PMC10394812.
      Citations:    Fields:    Translation:Humans
    25. Sanyal S, Calarge CA, Rowan PJ, Aparasu RR, Abughosh S, Chen H. Impact of the AACAP practice parameters on the metabolic adverse event monitoring for second-generation antipsychotics (SGAs) in children and adolescents. J Psychiatr Res. 2023 09; 165:170-173. PMID: 37506412.
      Citations: 1     Fields:    Translation:Humans
    26. Li J, Huang Y, Hutton GJ, Aparasu RR. Assessing treatment switch among patients with multiple sclerosis: A machine learning approach. Explor Res Clin Soc Pharm. 2023 Sep; 11:100307. PMID: 37554927; PMCID: PMC10405092.
      Citations:    
    27. Huang Y, Chatterjee S, Agarwal SK, Chen H, Johnson ML, Aparasu RR. Factors influencing prescribing the first add-on disease-modifying antirheumatic drugs in patients initiating methotrexate for rheumatoid arthritis. Explor Res Clin Soc Pharm. 2023 Sep; 11:100296. PMID: 37521021; PMCID: PMC10372178.
      Citations:    
    28. Kwak MJ, Schaefer C, Krause TM, Goyal P, Kim DH, Dhoble A, Johnson M, Aparasu R, Holmes HM. The median doses of beta-blockers among older adults with heart failure with reduced ejection fraction. J Am Geriatr Soc. 2023 10; 71(10):3322-3325. PMID: 37260084; PMCID: PMC10592593.
      Citations: 1     Fields:    Translation:Humans
    29. Earla JR, Li J, Hutton GJ, Johnson ML, Aparasu RR. Comparative adherence trajectories of oral disease-modifying agents in multiple sclerosis. Pharmacotherapy. 2023 06; 43(6):473-484. PMID: 37157135.
      Citations:    Fields:    Translation:Humans
    30. Zakeri M, Li J, Sansgiry SS, Aparasu RR. Incremental health care expenditures for non-Hodgkin lymphoma in comparison with other cancers: Analysis of national survey data. J Manag Care Spec Pharm. 2023 May; 29(5):480-489. PMID: 37121258; PMCID: PMC10387904.
      Citations: 1     Fields:    Translation:Humans
    31. Huang Y, Talwar A, Lin Y, Aparasu RR. Machine learning methods to predict 30-day hospital readmission outcome among US adults with pneumonia: analysis of the national readmission database. BMC Med Inform Decis Mak. 2022 11 09; 22(1):288. PMID: 36352392; PMCID: PMC9643900.
      Citations: 1     Fields:    Translation:Humans
    32. Kwak MJ, Cheng M, Goyal P, Kim DH, Hummel SL, Dhoble A, Deshmukh A, Aparasu R, Holmes HM. Medication Complexity Among Older Adults with HF: How Can We Assess Better? Drugs Aging. 2022 11; 39(11):851-861. PMID: 36227408; PMCID: PMC9701093.
      Citations: 4     Fields:    Translation:Humans
    33. Talwar A, Estes E, Aparasu R, Reddy DS. Clinical efficacy and safety of cannabidiol for pediatric refractory epilepsy indications: A systematic review and meta-analysis. Exp Neurol. 2023 01; 359:114238. PMID: 36206805.
      Citations: 15     Fields:    Translation:Humans
    34. Chikermane SG, Sharma M, Abughosh SM, Aparasu RR, Trivedi MV, Johnson ML. Dose-dependent relation between metformin and the risk of hormone receptor-positive, her2-negative breast cancer among postmenopausal women with type-2 diabetes. Breast Cancer Res Treat. 2022 Oct; 195(3):421-430. PMID: 35969285.
      Citations: 4     Fields:    Translation:Humans
    35. Nair AA, Placencia JL, Farber HJ, Aparasu RR, Johnson M, Chen H. Association Between Initial Opioid Prescription Duration and 30-Day Risk of Receiving Repeat Opioid Among Children. Acad Pediatr. 2023 03; 23(2):416-424. PMID: 35863737.
      Citations: 1     Fields:    Translation:Humans
    36. Li J, Zakeri M, Hutton GJ, Aparasu RR. Health-related quality of life of patients with multiple sclerosis: Analysis of ten years of national data. Mult Scler Relat Disord. 2022 Oct; 66:104019. PMID: 35839614.
      Citations: 1     Fields:    Translation:Humans
    37. Talwar A, Rege S, Aparasu RR. Pain management practices for outpatients with breast cancer. Explor Res Clin Soc Pharm. 2022 Jun; 6:100155. PMID: 35865110; PMCID: PMC9294324.
      Citations: 1     
    38. Masurkar PP, Chatterjee S, Sherer JT, Chen H, Johnson ML, Aparasu RR. Risk of Serious Adverse Events Associated With Individual Cholinesterase Inhibitors Use in Older Adults With Dementia: A Population-Based Cohort Study. Drugs Aging. 2022 06; 39(6):453-465. PMID: 35666463.
      Citations: 3     Fields:    Translation:Humans
    39. Li J, Chikermane SG, Earla JR, Hutton GJ, Aparasu RR. FACTORS ASSOCIATED WITH SWITCHING FROM INJECTABLE TO ORAL DISEASE MODIFYING AGENTS AMONG PATIENTS WITH MULTIPLE SCLEROSIS. Mult Scler Relat Disord. 2022 Apr; 60:103703. PMID: 35278846.
      Citations: 1     Fields:    Translation:Humans
    40. Kwak MJ, Chang M, Chiadika S, Aguilar D, Avritscher E, Deshmukh A, Goyal P, Kim DH, Aparasu R, Holmes HM. Healthcare Expenditure Associated With Polypharmacy in Older Adults With Cardiovascular Diseases. Am J Cardiol. 2022 04 15; 169:156-158. PMID: 35168755; PMCID: PMC9313779.
      Citations: 6     Fields:    Translation:Humans
    41. Turana Y, Nathaniel M, Shen R, Ali S, Aparasu RR. Citicoline and COVID-19-Related Cognitive and Other Neurologic Complications. Brain Sci. 2021 Dec 31; 12(1). PMID: 35053804; PMCID: PMC8782421.
      Citations: 12     
    42. Masurkar PP, Chatterjee S, Sherer JT, Chen H, Johnson ML, Aparasu RR. Risk of overactive bladder associated with cholinesterase inhibitors in dementia. J Am Geriatr Soc. 2022 03; 70(3):820-830. PMID: 34854475.
      Citations:    Fields:    Translation:Humans
    43. Upadhyay N, Rowan PJ, Aparasu RR, Balkrishnan R, Fleming ML, Nair AA, Chen H. Impact of geographic access to primary care providers on pediatric behavioral health screening. Prev Med. 2021 12; 153:106856. PMID: 34678330.
      Citations: 1     Fields:    Translation:Humans
    44. Huang Y, Rege S, Chatterjee S, Aparasu RR. Opioid Prescribing Among Outpatients with Rheumatoid Arthritis. Pain Med. 2021 10 08; 22(10):2224-2234. PMID: 33565582.
      Citations: 2     Fields:    Translation:Humans
    45. Talwar A, Earla JR, Hutton GJ, Aparasu RR. Prescribing of disease modifying agents in older adults with multiple sclerosis. Mult Scler Relat Disord. 2022 Jan; 57:103308. PMID: 35158421.
      Citations:    Fields:    Translation:Humans
    46. Chatterjee S, Walker D, Kimura T, Aparasu RR. The Costs and Healthcare Resource Utilization Associated with Anticholinergic Burden in Long-Stay Nursing Home Residents with Overactive Bladder in the US. Pharmacoecon Open. 2021 Dec; 5(4):727-736. PMID: 34255290; PMCID: PMC8611128.
      Citations: 1     
    47. Aparasu RR, Rege S. National surveys to evaluate prescribing practices: Methodological considerations. Res Social Adm Pharm. 2022 02; 18(2):2317-2324. PMID: 34253469.
      Citations:    Fields:    Translation:Humans
    48. Kobayashi M, Kwak MJ, Aguilar D, Goyal P, Holmes HM, Deshmukh AA, Aparasu RR. Prescribing Trend of Inappropriate Medications in Outpatient Clinics for Older Adults With Heart Failure in the United States: NAMCS 2012 to 2016. Am J Cardiol. 2021 08 01; 152:168. PMID: 34045051; PMCID: PMC9190247.
      Citations:    Fields:    Translation:Humans
    49. Masurkar PP, Chatterjee S, Sherer JT, Aparasu RR. Antimuscarinic Cascade Across Individual Cholinesterase Inhibitors in Older Adults with Dementia. Drugs Aging. 2021 07; 38(7):593-602. PMID: 34027602.
      Citations: 3     Fields:    Translation:Humans
    50. Kachru N, Holmes HM, Johnson ML, Chen H, Aparasu RR. Antimuscarinic use among older adults with dementia and overactive bladder: a Medicare beneficiaries study. Curr Med Res Opin. 2021 08; 37(8):1303-1313. PMID: 33890538; PMCID: PMC9289997.
      Citations: 5     Fields:    Translation:Humans
    51. Huang Y, Talwar A, Chatterjee S, Aparasu RR. Application of machine learning in predicting hospital readmissions: a scoping review of the literature. BMC Med Res Methodol. 2021 05 06; 21(1):96. PMID: 33952192; PMCID: PMC8101040.
      Citations: 23     Fields:    
    52. Earla JR, Hutton GJ, Thornton JD, Chen H, Johnson ML, Aparasu RR. Factors associated with oral fingolimod use over injectable disease- modifying agent use in multiple sclerosis. Explor Res Clin Soc Pharm. 2021 Jun; 2:100021. PMID: 35481133; PMCID: PMC9031432.
      Citations: 1     
    53. Rege S, Carnahan RM, Johnson ML, Chen H, Holmes HM, Aparasu RR. Antipsychotic Initiation Among Older Dementia Patients Using Cholinesterase Inhibitors: A National Retrospective Cohort Study. Drugs Aging. 2021 06; 38(6):493-502. PMID: 33763822.
      Citations: 1     Fields:    Translation:Humans
    54. Earla JR, Hutton GJ, Thornton DJ, Chen H, Johnson ML, Aparasu RR. Comparative treatment effectiveness of oral fingolimod and conventional injectable disease-modifying agents in multiple sclerosis. Pharmacotherapy. 2021 05; 41(5):440-450. PMID: 33641232.
      Citations:    Fields:    Translation:Humans
    55. Chatterjee S, Walker D, Kimura T, Aparasu RR. Prevalence and Factors Associated with Cumulative Anticholinergic Burden Among Older Long-Stay Nursing Home Residents with Overactive Bladder. Drugs Aging. 2021 04; 38(4):311-326. PMID: 33682017; PMCID: PMC8007511.
      Citations: 1     Fields:    Translation:Humans
    56. Kachru N, Holmes HM, Johnson ML, Chen H, Aparasu RR. Comparative risk of adverse outcomes associated with nonselective and selective antimuscarinic medications in older adults with dementia and overactive bladder. Int J Geriatr Psychiatry. 2021 05; 36(5):684-696. PMID: 33169433; PMCID: PMC9290172.
      Citations: 5     Fields:    Translation:Humans
    57. Earla JR, Hutton GJ, Thornton JD, Chen H, Johnson ML, Aparasu RR. Comparative Adherence Trajectories of Oral Fingolimod and Injectable Disease Modifying Agents in Multiple Sclerosis. Patient Prefer Adherence. 2020; 14:2187-2199. PMID: 33177813; PMCID: PMC7649232.
      Citations: 5     
    58. Sura S, Shiozawa A, Ng D, Aparasu RR. Higher Resource Utilization and Costs in Long-Term Nursing Home Residents With Overactive Bladder: A Retrospective Study of Medicare Beneficiaries. J Am Med Dir Assoc. 2021 06; 22(6):1300-1306. PMID: 33071158.
      Citations: 2     Fields:    Translation:Humans
    59. Chatterjee S, Talwar A, Aparasu RR. Anticholinergic medications and risk of dementia in older adults: Where are we now? Expert Opin Drug Saf. 2020 Oct; 19(10):1251-1267. PMID: 32797761.
      Citations: 5     Fields:    Translation:HumansAnimals
    60. Aparasu RR, Sura S, Earla JR, Shiozawa A, Ng DB, Schermer CR. Antimuscarinic Discontinuation in Patients with Overactive Bladder in Nursing Homes: A Retrospective Study of Medicare Beneficiaries. Adv Ther. 2020 08; 37(8):3584-3605. PMID: 32638205; PMCID: PMC7370971.
      Citations: 1     Fields:    Translation:Humans
    61. Earla JR, Hutton GJ, Thornton JD, Aparasu RR. Factors Associated with Prescribing Oral Disease Modifying Agents in Multiple Sclerosis: a Real-world Analysis of Electronic Medical Records. Mult Scler Relat Disord. 2020 Oct; 45:102334. PMID: 32629400.
      Citations: 1     Fields:    Translation:Humans
    62. Earla JR, Thornton JD, Hutton GJ, Aparasu RR. Marginal Health Care Expenditure Burden Among U.S. Civilian Noninstitutionalized Individuals with Multiple Sclerosis: 2010-2015. J Manag Care Spec Pharm. 2020 Jun; 26(6):741-749. PMID: 32463779; PMCID: PMC10391019.
      Citations: 6     Fields:    Translation:Humans
    63. Earla JR, Paranjpe R, Kachru N, Hutton GJ, Aparasu RR. Use of disease modifying agents in patients with multiple sclerosis: Analysis of ten years of national data. Res Social Adm Pharm. 2020 Dec; 16(12):1670-1676. PMID: 32171597.
      Citations: 1     Fields:    Translation:Humans
    64. Chekani F, Holmes HM, Johnson ML, Chen H, Sherer JT, Aparasu RR. Risk of Mortality Associated With Atypical Antipsychotic use: A National Cohort Study of Older Adults With Depression and Parkinson's Disease. Am J Geriatr Psychiatry. 2020 10; 28(10):1079-1088. PMID: 32147383.
      Citations: 1     Fields:    Translation:Humans
    65. Kachru N, Holmes HM, Johnson ML, Chen H, Aparasu RR. Risk of Mortality Associated with Non-selective Antimuscarinic medications in Older Adults with Dementia: a Retrospective Study. J Gen Intern Med. 2020 07; 35(7):2084-2093. PMID: 32026255; PMCID: PMC7351941.
      Citations: 11     Fields:    Translation:Humans
    66. Chekani F, Holmes HM, Johnson ML, Chen H, Sherer JT, Aparasu RR. Use of Atypical Antipsychotics in Long-Term Care Residents with Parkinson's Disease and Comorbid Depression. Drug Healthc Patient Saf. 2020; 12:23-30. PMID: 32099480; PMCID: PMC6999551.
      Citations: 3     
    67. Yucel A, Sanyal S, Essien EJ, Mgbere O, Aparasu R, Bhatara VS, Alonzo JP, Chen H. Racial/ethnic differences in treatment quality among youth with primary care provider-initiated versus mental health specialist-initiated care for major depressive disorders. Child Adolesc Ment Health. 2020 02; 25(1):28-35. PMID: 32285643.
      Citations: 2     Fields:    Translation:Humans
    68. Pavuluri N, Aparasu RR, Boje KMK, Danielson J, El-Ibiary SY, Iyer AKV, Ochs LA, Robinson JD, Shah S, Williams CC, Moore TM, Wargo KA. Consideration of Aggressive and Strategic Approaches to Address Declining Enrollment in US Pharmacy Schools. Am J Pharm Educ. 2019 08; 83(6):6959. PMID: 31507290; PMCID: PMC6718500.
      Citations: 16     Fields:    Translation:Humans
    69. Chekani F, Holmes HM, Johnson ML, Chen H, Sherer JT, Aparasu RR. Risk of pneumonia associated with atypical antipsychotic use in nursing home residents with Parkinson's disease. J Psychiatr Res. 2019 10; 117:116-121. PMID: 31377483.
      Citations: 4     Fields:    Translation:Humans
    70. Chatterjee S, Bali V, Carnahan RM, Chen H, Johnson ML, Aparasu RR. Anticholinergic burden and risk of cognitive impairment in elderly nursing home residents with depression. Res Social Adm Pharm. 2020 03; 16(3):329-335. PMID: 31182419.
      Citations: 11     Fields:    Translation:Humans
    71. Upadhyay N, Patel A, Chan W, Aparasu RR, Ochoa-Perez M, Sherer JT, Sanyal S, Chen H. Reversibility of psychotropic medication induced weight gain among children and adolescents with bipolar disorders. Psychiatry Res. 2019 06; 276:151-159. PMID: 31085419.
      Citations: 5     Fields:    Translation:Humans
    72. Upadhyay N, Aparasu R, Rowan PJ, Fleming ML, Balkrishnan R, Chen H. The association between geographic access to providers and the treatment quality of pediatric depression. J Affect Disord. 2019 06 15; 253:162-170. PMID: 31035217.
      Citations: 2     Fields:    Translation:Humans
    73. Rege S, Kavati A, Ortiz B, Mosnaim G, Cabana MD, Murphy K, Aparasu RR. Documentation of asthma control and severity in pediatrics: analysis of national office-based visits. J Asthma. 2020 02; 57(2):205-216. PMID: 30657001.
      Citations: 4     Fields:    Translation:Humans
    74. Rege S, Kavati A, Ortiz B, Mosnaim G, Cabana MD, Murphy K, Aparasu RR. Asthma Medication Prescribing Practices in Pediatric Office Visits. Clin Pediatr (Phila). 2019 04; 58(4):395-405. PMID: 30614250.
      Citations: 1     Fields:    Translation:Humans
    75. Sharma M, Holmes HM, Mehta HB, Chen H, Aparasu RR, Shih YT, Giordano SH, Johnson ML. The concomitant use of tyrosine kinase inhibitors and proton pump inhibitors: Prevalence, predictors, and impact on survival and discontinuation of therapy in older adults with cancer. Cancer. 2019 04 01; 125(7):1155-1162. PMID: 30605231; PMCID: PMC6420393.
      Citations: 39     Fields:    Translation:Humans
    76. Medhekar R, Fujimoto K, Aparasu RR, Bhatara VS, Johnson ML, Alonzo JP, Schwarzwald HL, Chen H. Physician Care Coordination and the Use of Psychotropic Polypharmacy in the Management of Pediatric Mental Disorders. J Manag Care Spec Pharm. 2019 Jan; 25(1):29-38. PMID: 30589632; PMCID: PMC10397634.
      Citations: 3     Fields:    Translation:Humans
    77. Holmes HM, Aparasu RR. Acetylcholinesterase Inhibitors: Start Low or Risk Going Slow? J Am Geriatr Soc. 2018 09; 66(9):1663-1664. PMID: 30098203.
      Citations:    Fields:    Translation:Humans
    78. Medhekar R, Aparasu R, Bhatara V, Johnson M, Alonzo J, Schwarzwald H, Chen H. Risk factors of psychotropic polypharmacy in the treatment of children and adolescents with psychiatric disorders. Res Social Adm Pharm. 2019 04; 15(4):395-403. PMID: 29929905.
      Citations: 10     Fields:    Translation:Humans
    79. Dotson KM, Aitken SL, Sofjan AK, Shah DN, Aparasu RR, Garey KW. Outcomes associated with Clostridium difficile infection in patients with chronic liver disease. Epidemiol Infect. 2018 07; 146(9):1101-1105. PMID: 29739486; PMCID: PMC6057822.
      Citations: 13     Fields:    Translation:Humans
    80. Yucel A, Essien EJ, Sanyal S, Mgbere O, Aparasu RR, Bhatara VS, Alonzo JP, Chen H. Racial/ethnic differences in the treatment of adolescent major depressive disorders (MDD) across healthcare providers participating in the medicaid program. J Affect Disord. 2018 08 01; 235:155-161. PMID: 29656260.
      Citations:    Fields:    Translation:Humans
    81. Aparasu RR, Rege S. FRAX tool underestimates the risk of osteoporotic fractures in mental disorders. Evid Based Ment Health. 2018 05; 21(2):80. PMID: 29463572; PMCID: PMC10270459.
      Citations:    Fields:    Translation:Humans
    82. Chatterjee S, Bali V, Carnahan RM, Chen H, Johnson ML, Aparasu RR. Risk of Mortality Associated with Anticholinergic Use in Elderly Nursing Home Residents with Depression. Drugs Aging. 2017 09; 34(9):691-700. PMID: 28656508.
      Citations: 14     Fields:    Translation:Humans
    83. Rege S, Sura S, Aparasu RR. Atypical antipsychotic prescribing in elderly patients with depression. Res Social Adm Pharm. 2018 07; 14(7):645-652. PMID: 28826692.
      Citations: 1     Fields:    Translation:Humans
    84. Patel A, Chan W, Aparasu RR, Ochoa-Perez M, Sherer JT, Medhekar R, Chen H. Effect of Psychopharmacotherapy on Body Mass Index Among Children and Adolescents with Bipolar Disorders. J Child Adolesc Psychopharmacol. 2017 May; 27(4):349-358. PMID: 28422528.
      Citations: 6     Fields:    Translation:Humans
    85. Upadhyay N, Chen H, Mgbere O, Bhatara VS, Aparasu RR. The Impact of Pharmacotherapy on Substance Use in Adolescents With Attention-Deficit/Hyperactivity Disorder: Variations Across Subtypes. Subst Use Misuse. 2017 08 24; 52(10):1266-1274. PMID: 28323525.
      Citations: 5     Fields:    Translation:Humans
    86. Bali V, Chatterjee S, Johnson ML, Chen H, Carnahan RM, Aparasu RR. Risk of Mortality in Elderly Nursing Home Patients with Depression Using Paroxetine. Pharmacotherapy. 2017 03; 37(3):287-296. PMID: 28079266.
      Citations: 2     Fields:    Translation:Humans
    87. Patel A, Medhekar R, Ochoa-Perez M, Aparasu RR, Chan W, Sherer JT, Alonzo J, Chen H. Care Provision and Prescribing Practices of Physicians Treating Children and Adolescents With ADHD. Psychiatr Serv. 2017 Jul 01; 68(7):681-688. PMID: 28196459.
      Citations: 12     Fields:    Translation:Humans
    88. Bali V, Chatterjee S, Johnson ML, Chen H, Carnahan RM, Aparasu RR. Risk of Cognitive Decline Associated With Paroxetine Use in Elderly Nursing Home Patients With Depression. Am J Alzheimers Dis Other Demen. 2016 12; 31(8):678-686. PMID: 27765867; PMCID: PMC10852634.
      Citations: 3     Fields:    Translation:Humans
    89. Colavecchia AC, Putney DR, Johnson ML, Aparasu RR. Discharge medication complexity and 30-day heart failure readmissions. Res Social Adm Pharm. 2017 Jul - Aug; 13(4):857-863. PMID: 27771308.
      Citations: 13     Fields:    Translation:Humans
    90. Kachru N, Sura S, Chatterjee S, Aparasu RR. Antimuscarinic Medication Use in Elderly Patients with Overactive Bladder. Drugs Aging. 2016 10; 33(10):755-763. PMID: 27681701.
      Citations: 6     Fields:    Translation:Humans
    91. Bali V, Chatterjee S, Johnson ML, Chen H, Carnahan RM, Aparasu RR. Comparative risk of hip fractures in elderly nursing home patients with depression using paroxetine and other selective serotonin reuptake inhibitors. J Comp Eff Res. 2016 08; 5(5):461-73. PMID: 27426927; PMCID: PMC4975023.
      Citations: 3     Fields:    Translation:Humans
    92. Chatterjee S, Bali V, Carnahan RM, Chen H, Johnson ML, Aparasu RR. Anticholinergic Medication Use and Risk of Fracture in Elderly Adults with Depression. J Am Geriatr Soc. 2016 07; 64(7):1492-7. PMID: 27294403.
      Citations: 14     Fields:    Translation:Humans
    93. Chekani F, Bali V, Aparasu RR. Functional Status of Elderly Nursing Home Residents With Parkinson's Disease. J Parkinsons Dis. 2016 06 02; 6(3):617-24. PMID: 27258696.
      Citations: 2     Fields:    Translation:Humans
    94. Rane PP, Guha S, Chatterjee S, Aparasu RR. Prevalence and predictors of non-evidence based proton pump inhibitor use among elderly nursing home residents in the US. Res Social Adm Pharm. 2017 Mar - Apr; 13(2):358-363. PMID: 27033427.
      Citations: 25     Fields:    Translation:Humans
    95. Chatterjee S, Bali V, Carnahan RM, Johnson ML, Chen H, Aparasu RR. Anticholinergic Medication Use and Risk of Dementia Among Elderly Nursing Home Residents with Depression. Am J Geriatr Psychiatry. 2016 06; 24(6):485-95. PMID: 26976294.
      Citations: 10     Fields:    Translation:Humans
    96. Chatterjee S, Carnahan RM, Chen H, Holmes HM, Johnson ML, Aparasu RR. Anticholinergic Medication Use and Risk of Pneumonia in Elderly Adults: A Nested Case-Control Study. J Am Geriatr Soc. 2016 Feb; 64(2):394-400. PMID: 26889844.
      Citations: 23     Fields:    Translation:Humans
    97. Bali V, Holmes HM, Johnson ML, Chen H, Fleming ML, Aparasu RR. Comparative Effectiveness of Second-Generation Antidepressants in Reducing the Risk of Dementia in Elderly Nursing Home Residents with Depression. Pharmacotherapy. 2016 Jan; 36(1):38-48. PMID: 26748455.
      Citations: 1     Fields:    Translation:Humans
    98. Mehta HB, Mehta V, Tsai CL, Chen H, Aparasu RR, Johnson ML. Development and Validation of the RxDx-Dementia Risk Index to Predict Dementia in Patients with Type 2 Diabetes and Hypertension. J Alzheimers Dis. 2016; 49(2):423-32. PMID: 26519436.
      Citations: 13     Fields:    Translation:Humans
    99. Chitnis AS, Aparasu RR, Chen H, Kunik ME, Schulz PE, Johnson ML. Use of Angiotensin-Converting Enzyme Inhibitors, Angiotensin Receptor Blockers, and Risk of Dementia in Heart Failure. Am J Alzheimers Dis Other Demen. 2016 08; 31(5):395-404. PMID: 26705381; PMCID: PMC10852826.
      Citations: 5     Fields:    Translation:Humans
    100. Bali V, Johnson ML, Chen H, Fleming ML, Holmes HM, Aparasu RR. Comparative Cognitive Profile of Second-Generation Antidepressants in Elderly Nursing Home Residents With Depression. Ann Pharmacother. 2016 Feb; 50(2):96-105. PMID: 26610873; PMCID: PMC4743756.
      Citations:    Fields:    Translation:Humans
    Aparasu's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (255)
    Explore
    _
    Co-Authors (9)
    Explore
    _
    Same Department Expand Description
    Explore
    _